EMA – Page 70 – Pharma.Tips

Transport qualification gaps during inspection – regulatory inspection outcome

Addressing Transport Qualification Gaps During Inspections: Strategies for Pharmaceutical Professionals In the highly regulated pharmaceutical industry, maintaining compliance during transport qualification is crucial for quality assurance and product integrity. Regulatory…

System access control failure during validation lifecycle – preventing repeat CSV observations

Addressing System Access Control Failures in Validation Lifecycle to Enhance Compliance In the complex world of pharmaceutical manufacturing and quality control, maintaining stringent guidelines is paramount. A recurring issue within…

Cold chain excursion not assessed during inspection – CAPA and system remediation

Assessing Cold Chain Excursions During Inspections: A Detailed Investigation Cold chain management is a crucial component in pharmaceutical manufacturing and distribution, as it ensures the integrity of temperature-sensitive products. When…

Data backup and restore failure during inspection walkthrough – preventing repeat CSV observations

Understanding Data Backup and Restore Failures During Inspection Walkthroughs Incidents of data backup and restore failures can significantly jeopardize compliance during regulatory inspections such as those conducted by the FDA,…

Distribution temperature breach during transportation – product quality risk assessment

Assessing Risks Related to Temperature Breaches During Transportation in Pharmaceuticals Temperature excursions during the transportation of pharmaceutical products can jeopardize product integrity and patient safety. Such violations present a significant…

Data backup and restore failure during system operation – preventing repeat CSV observations

Understanding and Addressing Data Backup and Restore Failures in Pharmaceutical Operations Data integrity is a crucial aspect of pharmaceutical manufacturing and quality operations, as it supports compliant decision-making and regulatory…

Excursion trend ignored during inspection – how to prevent repeat excursions

Addressing Ignored Excursion Trends During Inspection to Prevent Repetitive Issues In a highly regulated pharmaceutical manufacturing environment, overlooking excursion trends during inspections can lead to severe compliance risks, including regulatory…

Audit trail gaps identified during data integrity review – CAPA and revalidation strategy

“`html Identifying and Investigating Audit Trail Gaps During Data Integrity Reviews In the highly regulated environment of pharmaceutical manufacturing, the integrity of data and compliance with Good Manufacturing Practices (GMP)…

Transport qualification gaps during distribution qualification – product quality risk assessment

“`html Addressing Gaps in Transport Qualification During Distribution Qualification to Ensure Product Quality Pharmaceutical professionals often face challenges related to transport qualification gaps during the distribution qualification process. These gaps…

Tag: EMA